← Eichor
Condition: Cholangitis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cholangitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
Phase 3 · 42 location(s) · Cascade Pharmaceuticals, Inc · NCT07282353Prospective Cohort of Immune Checkpoint Inhibitor-induced Hepatitis
Phase N/A · 1 location(s) · University Hospital, Montpellier · NCT06864481Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)
Phase N/A · 18 location(s) · PSC Partners Seeking a Cure · NCT06297993Fenofibrate in Primary Biliary Cholangitis: a Real World Study
Phase 3 · 1 location(s) · Xijing Hospital of Digestive Diseases · NCT06755151A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Phase 3 · 186 location(s) · Ipsen · NCT06016842Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease
Phase 1 · 1 location(s) · Zydus Therapeutics Inc. · NCT06825559Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
Phase N/A · 1 location(s) · Chungnam National University Hospital · NCT06519162Biochemical Response and Clinical Outcomes in Patients With PBC
Phase N/A · 1 location(s) · RenJi Hospital · NCT07449793Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · 205 location(s) · Gilead Sciences · NCT06051617A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC)
Phase 1 · 1 location(s) · Takeda · NCT07229911Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation
Phase 2 · 1 location(s) · Mayo Clinic · NCT06905054RELIEF: Multimodal Prehabilitation to Treat Fatigue in Patients With Primary Biliary Cholangitis
NA · 1 location(s) · Hospital Clinic of Barcelona · NCT07161245Colangioids to Define the Genetic Factors Involved in Atypical Primary Sclerosing Cholangitis
NA · 1 location(s) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT06865924Primary Sclerosing Cholangitis in Children
Phase N/A · 12 location(s) · Arbor Research Collaborative for Health · NCT04181138A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
Phase 2 · 7 location(s) · LISCure Biosciences · NCT06699121Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study
EARLY_Phase 1 · 1 location(s) · Stanford University · NCT05912387Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study
Phase 3 · 1 location(s) · Xijing Hospital of Digestive Diseases · NCT06755541Sedation Methods in Percutaneous Transhepatic Biliary Drainage: Procedure Quality and Recovery
NA · 1 location(s) · Ankara City Hospital Bilkent · NCT07640243Efficacy of Fistulotomy for Biliary Cannulation
NA · 1 location(s) · Coordinación de Investigación en Salud, Mexico · NCT04037007Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
Phase 1 · 1 location(s) · Sacramento Pediatric Gastroenterology · NCT02137668Biobank for Cholestatic Liver Diseases.
Phase N/A · 1 location(s) · Mayo Clinic · NCT03445585Efficacy and Safety of Bezafibrate 400 mg and Bezafibrate 200 mg as Adjunctive Treatments in Patients With Primary Bilia
Phase 3 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06443606Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy
NA · 1 location(s) · Children's Hospital of Fudan University · NCT05925309FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis
Phase 2 · 5 location(s) · University of Birmingham · NCT06286709Detoxification of the Liver In PSC (Dolphin)
Phase 2 · 1 location(s) · Brigham and Women's Hospital · NCT05835505Composite Index for Outcome Burden in Acute Cholangitis
Phase N/A · 1 location(s) · Asian Institute of Gastroenterology, India · NCT07667166An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis
Phase N/A · 1 location(s) · University of Copenhagen · NCT05335603Swiss Primary Sclerosing Cholangitis Cohort Study
Phase N/A · 21 location(s) · Fondazione Epatocentro Ticino · NCT03146936Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)
Phase 2/Phase 3 · 1 location(s) · Xijing Hospital of Digestive Diseases · NCT06365424Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis.
Phase 2 · 2 location(s) · Aparna Goel · NCT05295680
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.